FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

8652911000001106: Fosamprenavir 50mg/ml oral suspension 225 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
23136901000001114 Fosamprenavir 50mg/ml oral suspension 225 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
23137001000001113 Fosamprenavir 50mg/ml oral suspension 225 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Fosamprenavir 50mg/ml oral suspension 225 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Fosamprenavir 50mg/ml oral suspension 225 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Fosamprenavir 50mg/ml oral suspension 225 ml Is pack of Fosamprenavir 50mg/ml oral suspension false Inferred relationship Existential restriction modifier
Fosamprenavir 50mg/ml oral suspension 225 ml VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Fosamprenavir 50mg/ml oral suspension 225 ml Has active ingredient Fosamprenavir calcium false Inferred relationship Existential restriction modifier
Fosamprenavir 50mg/ml oral suspension 225 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Fosamprenavir 50mg/ml oral suspension 225 ml VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Fosamprenavir 50mg/ml oral suspension 225 ml Is pack of Product containing precisely fosamprenavir (as fosamprenavir calcium) 50 milligram/1 milliliter conventional release oral suspension false Inferred relationship Existential restriction modifier
Fosamprenavir 50mg/ml oral suspension 225 ml Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Fosamprenavir 50mg/ml oral suspension 225 ml Has VMP Product containing precisely fosamprenavir (as fosamprenavir calcium) 50 milligram/1 milliliter conventional release oral suspension true Inferred relationship Existential restriction modifier
Fosamprenavir 50mg/ml oral suspension 225 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Fosamprenavir true Inferred relationship Existential restriction modifier
Fosamprenavir 50mg/ml oral suspension 225 ml Has specific active ingredient Fosamprenavir calcium true Inferred relationship Existential restriction modifier
Fosamprenavir 50mg/ml oral suspension 225 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Fosamprenavir 50mg/ml oral suspension 225 ml Has basis of strength substance Fosamprenavir true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Telzir 50mg/ml oral suspension (GlaxoSmithKline) 225 ml Is a True Fosamprenavir 50mg/ml oral suspension 225 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start